版本:
中国

BRIEF-Can-Fite files clinical trial application in Canada for Piclidenoson

May 16 Can Fite Biopharma Ltd

* Can-Fite files clinical trial application in canada for piclidenoson ahead of upcoming acrobat rheumatoid arthritis phase iii study

* Can fite biopharma ltd says intends to commence its phase iii acrobat trial of piclidenoson in treatment of rheumatoid arthritis in q2 of 2017

* Can fite biopharma ltd - can-fite intends to commence its phase iii acrobat trial of piclidenoson in treatment of rheumatoid arthritis in q2 of 2017. Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐